Team

Our team covers a broad spectrum of expertise and knowhow making it possible to design, engineer, develop and validate our antibody-fusion lead candidates OPS-121 for the treatment of AML and OPS-301 for the treatment of solid tumors. 

We are located at the Gene Center Munich and closely collaborating with the laboratories of Prof. Karl-Peter Hopfner granting access to equipment for protein engineering, purification and validation as well as scientific support. The close collaboration with Prof. Marion Subklewe, a leading and globally renown AML expert, involved in many clinical trials provides clinical experience, allows access to AML patient material and flow cytometry facilities.